Počet záznamov: 1
Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats
Názov Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats Autor Klimas Ján Spoluautori Olvedy Michael Ochodnická-Mackovičová Katarína Kružliak Peter 1982- Čačányiová Soňa 1971- SAVNOPAT - Ústav normálnej a patologickej fyziológie SAV SCOPUS ORCID Kristek František 1948-2018 SAVNOPAT - Ústav normálnej a patologickej fyziológie SAV Krenek Peter Ochodnický Peter Zdroj.dok. Journal of Cellular and Molecular Medicine. Vol. 19, no. 8 (2015), p. 1965-1974 Jazyk dok. eng - angličtina Poznámky APVV-0887-11; VEGA 1/0564/13, 2/0074/14, 1/0294/15, FNUSA-ICRC (no. CZ.1.05/1.1.00/02.0123) Druh dok. rozpis článkov z periodík (rbx) Ohlasy WANG, X.X. - YE, Y. - GONG, H. - WU, J. - YUAN, J. - WANG, S.J. - YIN, P.P. - DING, Z.W. - KANG, L. - JIANG, Q. - ZHANG, W.J. - LI, Y. - GE, J.B. - ZOU, Y.Z. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice. In JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. ISSN 0022-2828, AUG 2016, vol. 97, p. 180-190. WANG, L.P. - FAN, S.J. - LI, S.M. - WANG, X.J. - GAO, J.L. - YANG, X.H. Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating K(Ca)3.1 channel via ERK1/2 pathway. In PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY. ISSN 0031-6768, NOV 2016, vol. 468, no. 11-12, p. 2041-2051. PATTEN, G.S. - ABEYWARDENA, M.Y. Effects of Antihypertensive Agents on Intestinal Contractility in the Spontaneously Hypertensive Rat: Angiotensin Receptor System Downregulation by Losartan. In JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. ISSN 0022-3565, FEB 1 2017, vol. 360, no. 2, p. 260-266. CULVER, S. - LI, C.X. - SIRAGY, H.M. Intrarenal Angiotensin-Converting Enzyme: the Old and the New. In CURRENT HYPERTENSION REPORTS. ISSN 1522-6417, OCT 2017, vol. 19, no. 10. LEZAMA-MARTINEZ, D. - VALENCIA-HERNANDEZ, I. - FLORES-MONROY, J. - MARTINEZ-AGUILAR, L. Combination of beta Adrenergic Receptor Block and Renin-Angiotensin System Inhibition Diminished the Angiotensin II-Induced Vasoconstriction and Increased Bradykinin-Induced Vasodilation in Hypertension. In DOSE-RESPONSE. ISSN 1559-3258, NOV 12 2017, vol. 15, no. 4. MATA-GREENWOOD, E. - BLOOD, A.B. - SANDS, L.D. - BRAGG, S.L. - XIAO, D.L. - ZHANG, L.B. A novel rodent model of pregnancy complications associated with genetically determined angiotensin-converting enzyme (ACE) activity. In AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. ISSN 0193-1849, JUL 2018, vol. 315, no. 1, p. E52-E62. LIAO, W. - BHULLAR, K.S. - CHAKRABARTI, S. - DAVIDGE, S.T. - WU, J.P. Egg White-Derived Tripeptide IRW (Ile-Arg-Trp) Is an Activator of Angiotensin Converting Enzyme 2. In JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY. ISSN 0021-8561, OCT 31 2018, vol. 66, no. 43, p. 11330-11336. BONETTO, J.H.P. - FERNANDES, R.O. - DARTORA, D.R. - FLAHAULT, A. - SONEA, A. - CLOUTIER, Y.A. - BELLO-KLEIN, A. - NUYT, A.M. Impact of early life AT(1) blockade on adult cardiac morpho-functional changes and the renin-angiotensin system in a model of neonatal high oxygen-induced cardiomyopathy. In EUROPEAN JOURNAL OF PHARMACOLOGY. ISSN 0014-2999, 2019, vol. 860, article no: UNSP 172585, DOI: 10.1016/j.ejphar.2019.172585. BUALEONG, T. - WYSS, J.M. - ROYSOMMUTI, S. Inhibition of Renin-Angiotensin System from Conception to Young Mature Life Induces Salt-Sensitive Hypertension via Angiotensin II-Induced Sympathetic Overactivity in Adult Male Rats. In TAURINE 11. ISSN 0065-2598, 2019, vol. 1155, p. 45-59. D'ARDES, D. - BOCCATONDA, A. - ROSSI, I. - GUAGNANO, M.T. - SANTILLI, F. - CIPOLLONE, F. - BUCCI, M. COVID-19 and RAS: Unravelling an Unclear Relationship. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. APR 2020, vol. 21, no. 8, art. no. 3003. BOURGONJE, A.R. - ABDULLE, A.E. - TIMENS, W. - HILLEBRANDS, J.L. - NAVIS, G.J. - GORDIJN, S.J. - BOLLING, M.C. - DIJKSTRA, G. - VOORS, A.A. - OSTERHAUS, A.D.M.E. - VAN DER VOORT, P.H.J. - MULDER, D.J. - VAN GOOR, H. Angiotensin-converting enzyme 2 (ACE2),SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). In JOURNAL OF PATHOLOGY. ISSN 0022-3417, JUL 2020, vol. 251, no. 3, p. 228-248. DARIYA, B. - NAGARAJU, G.P. Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients. In CYTOKINE & GROWTH FACTOR REVIEWS. ISSN 1359-6101, JUN 2020, vol. 53, p. 43-52. SCHRODER, I. COVID-19: A Risk Assessment Perspective. In ACS CHEMICAL HEALTH & SAFETY. MAY 26 2020, vol. 27, no. 3, p. 160-169. CLERKIN, K.J. - FRIED, J.A. - RAIKHELKAR, J. - SAYER, G. - GRIFFIN, J.M. - MASOUMI, A. - JAIN, S.S. - BURKHOFF, D. - KUMARAIAH, D. - RABBANI, L. - SCHWARTZ, A. - URIEL, N. COVID-19 and Cardiovascular Disease. In CIRCULATION. ISSN 0009-7322, MAY 19 2020, vol. 141, no. 20, p. 1648-1655. ASKIN, L. - TANRIVERDI, O. - ASKIN, H.S. The Effect of Coronavirus Disease 2019 on Cardiovascular Diseases. In ARQUIVOS BRASILEIROS DE CARDIOLOGIA. ISSN 0066-782X, MAY 2020, vol. 114, no. 5, p. 817-822. LIPPI, G. - WONG, J. - HENRY, B.M. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. In POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ. ISSN 0032-3772, APR 30 2020, vol. 130, no. 4, p. 304-309. KOW, C.S. - ZAIDI, S.T.R. - HASAN, S.S. Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19. In AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS. ISSN 1175-3277, JUN 2020, vol. 20, no. 3, p. 217-221. KAKODKAR, P. - KAKA, N. - BAIG, M.N. A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19). In CUREUS. APR 6 2020, vol. 12, no. 4, art. no. e7560. SILHOL, F. - SARLON, G. - DEHARO, J.C. - VAISSE, B. Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system?. In HYPERTENSION RESEARCH. ISSN 0916-9636, AUG 2020, vol. 43, no. 8, p. 854-856. ALBINI, A. - DI GUARDO, G. - NOONAN, D.M. - LOMBARDO, M. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies. In INTERNAL AND EMERGENCY MEDICINE. ISSN 1828-0447, AUG 2020, vol. 15, no. 5, SI, p. 759-766. GURWITZ, D. Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. In DRUG DEVELOPMENT RESEARCH. ISSN 0272-4391, AUG 2020, vol. 81, no. 5, p. 537-540. BATTISTONI, A. - VOLPE, M. Might renin-angiotensin system blockers play a role in the COVID-19 pandemic?. In EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. ISSN 2055-6837, JUL 2020, vol. 6, no. 4, p. 248-251. MICHAUD, V. - DEODHAR, M. - ARWOOD, M. - AL RIHANI, S.B. - DOW, P. - TURGEON, J. ACE2 as a Therapeutic Target for COVID-19; Its Role in Infectious Processes and Regulation by Modulators of the RAAS System. In JOURNAL OF CLINICAL MEDICINE. JUL 2020, vol. 9, no. 7, art. no. 2096. BAVISHI, C. - MADDOX, T.M. - MESSERLI, F.H. Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers. In JAMA CARDIOLOGY. ISSN 2380-6583, JUL 2020, vol. 5, no. 7, p. 745-747. LI, J.Y. - WANG, X.F. - CHEN, J. - ZHANG, H.M. - DENG, A.P. Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China. In JAMA CARDIOLOGY. ISSN 2380-6583, JUL 2020, vol. 5, no. 7, p. 825-830. BHASKAR, S. - RASTOGI, A. - CHATTU, V.K. - ADISESH, A. - THOMAS, P. - ALVARADO, N. - RIAHI, A.D. - VARUN, C.N. - PAI, A.U.R. - BARSAM, S. - WALKER, A.H. Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium. In FRONTIERS IN CARDIOVASCULAR MEDICINE. ISSN 2297-055X, JUN 16 2020, vol. 7, art. no. 112. SANCHIS-GOMAR, F. - LAVIE, C.J. - PEREZ-QUILIS, C. - HENRY, B.M. - LIPPI, G. Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 201p. In MAYO CLINIC PROCEEDINGS. ISSN 0025-6196, JUN 2020, vol. 95, no. 6, p. 1222-1230. PORTELA-ORTIZ, J. M.- GARZA-BENAVIDES, G. - OCAMPO-VALENCIA, D. B. P.. Perioperative management of the COVID-19 patient with cardiac, renal and neurological conditions. In Revista Mexicana de Anestesiologia. ISSN 01851012, 2020-01-01, 43, 4, pp. 241-244. RAMíREZ-SAGREDO, Andrea - RAMíREZ-REYES, Andrés - OCARANZA, María Paz - CHIONG, Mario - RIQUELME, Jaime A - JALIL, Jorge E. - LAVANDERO, Sergio. Antihipertensivos en pacientes con COVID-19. In Revista chilena de cardiología. ISSN 0718-8560, 04 2020, vol. 39, no. 1, p. 66-74. JIANG, X. - EALES, J.M. - SCANNALI, D. - NAZGIEWICZ, A. - PRESTES, P. - MAIER, M. - DENNIFF, M. - XU, X.G. - SALUJA, S. - CANO-GAMEZ, E. - WYSTRYCHOWSKI, W. - SZULINSKA, M. - ANTCZAK, A. - BYARS, S. - SKRYPNIK, D. - GLYDA, M. - KROL, R. - ZYWIEC, J. - ZUKOWSKA-SZCZECHOWSKA, E. - BURRELL, L.M. - WOOLF, A.S. - GREENSTEIN, A. - BOGDANSKI, P. - KEAVNEY, B. - MORRIS, A.P. - HEAGERTY, A. - WILLIAMS, B. - HARRAP, S.B. - TRYNKA, G. - SAMANI, N.J. - GUZIK, T.J. - CHARCHAR, F.J. - TOMASZEWSKI, M. Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney. In EUROPEAN HEART JOURNAL. ISSN 0195-668X, DEC 21 2020, vol. 41, no. 48, p. 4580-4588. GEPDIREMEN, A. - KUMAS, M. ACE-2, TMPRSS2 and Beyond; Promising Targets and Tools for COVID-19 Prophylaxis and Treatment. In BEZMIALEM SCIENCE. ISSN 2148-2373, DEC 2020, vol. 8, p. 79-83. LIM, J.H. - CHO, J.H. - JEON, Y. - KIM, J.H. - LEE, G.Y. - JEON, S. - NOH, H.W. - LEE, Y.H. - LEE, J. - CHANG, H.H. - JUNG, H.Y. - CHOI, J.Y. - PARK, S.H. - KIM, C.D. - KIM, Y.L. - KIM, S.W. Adverse impact of renin-angiotensin system blockade on the clinical course in hospitalized patients with severe COVID-19: a retrospective cohort study. In SCIENTIFIC REPORTS. ISSN 2045-2322, NOV 20 2020, vol. 10, no. 1, art. no. 20250. GILL, D. - ARVANITIS, M. - CARTER, P. - CORDERO, A.I.H. - JO, B. - KARHUNEN, V. - LARSSON, S.C. - LI, X. - LOCKHART, S.M. - MASON, A. - PASHOS, E. - SAHA, A. - TAN, V.Y. - ZUBER, V. - BOSSE, Y. - FAHLE, S. - HAO, K. - JIANG, T. - JOUBERT, P. - LUNT, A.C. - OUWEHAND, W.H. - ROBERTS, D.J. - TIMENS, W. - VAN DEN BERGE, M. - WATKINS, N.A. - BATTLE, A. - BUTTERWORTH, A.S. - DANESH, J. - DI ANGELANTONIO, E. - ENGELHARDT, B.E. - PETERS, J.E. - SIN, D.D. - BURGESS, S. ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study. In ROYAL SOCIETY OPEN SCIENCE. ISSN 2054-5703, NOV 18 2020, vol. 7, no. 11, art. no. 200958. FAHEEM - KUMAR, B.K. - SEKHAR, K.V.G.C. - KUNJIAPPAN, S. - JAMALIS, J. - BALANA-FOUCE, R. - TEKWANI, B.L. - SANKARANARAYANAN, M. Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19. In BIOORGANIC CHEMISTRY. ISSN 0045-2068, NOV 2020, vol. 104, art. no. 104269. CHATTERJEE, B. - THAKUR, S.S. ACE2 as a potential therapeutic target for pandemic COVID-19. In RSC ADVANCES. NOV 1 2020, vol. 10, no. 65, p. 39808-39813. CHEN, L. - HAO, G. The role of argiotensin-convertirg enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease. In CARDIOVASCULAR RESEARCH. ISSN 0008-6363, OCT 1 2020, vol. 116, no. 12, p. 1932-1936. GAO, Q. - LIU, J. - MU, Z.L. - VAN, X.P. - SHAH, J.N. - JIAO, F.Y. Clinical Profile of COVID-19 in Children and Research Progress on Angiotensin-converting Enzyme 2: A Mini-review. In JOURNAL OF NEPAL MEDICAL ASSOCIATION. ISSN 0028-2715, OCT 2020, vol. 58, no. 230, p. 813-819. HASAN, S.S. - KOW, C.S. - HADI, M.A. - ZAIDI, S.T.R. - MERCHANT, H.A. Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis. In AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS. ISSN 1175-3277, DEC 2020, vol. 20, no. 6, p. 571-590. VAZQUEZ-CORNEJO, E. Considerations on the use of antihypertensive blockers of the renin-angiotensin system in adults and children in the face of the COVID-19 pandemic. In BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO. ISSN 0539-6115, SEP-OCT 2020, vol. 77, no. 5, p. 274-281. LUMPUY-CASTILLO, J. - LORENZO-ALMOROS, A. - PELLO-LAZARO, A.M. - SANCHEZ-FERRER, C. - EGIDO, J. - TUNON, J. - PEIRO, C. - LORENZO, O. Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. SEP 2020, vol. 21, no. 18, art. no. 6471. TRIPATHI, S. - TRIPATHI, M.M. The COVID-19: Current understanding. In VETERINARY WORLD. ISSN 0972-8988, SEP 2020, vol. 13, no. 9, p. 1998-2005. PENMAN, S.L. - KIY, R.T. - JENSEN, R.L. - BEOKU-BETTS, C. - ALFIREVIC, A. - BACK, D. - KHOO, S.H. - OWEN, A. - PIRMOHAMED, M. - PARK, B.K. - MENG, X.L. - GOLDRING, C.E. - CHADWICK, A.E. Safety perspectives on presently considered drugs for the treatment of COVID-19. In BRITISH JOURNAL OF PHARMACOLOGY. ISSN 0007-1188, OCT 2020, vol. 177, no. 19, p. 4353-4374. GOMMANS, D.H.F. - NAS, J. - PINTO-SIETSMA, S.J. - KOOP, Y. - KONST, R.E. - MENSINK, F. - AARTS, G.W.A. - KONIJNENBERG, L.S.F. - CORTENBACH, K. - VERHAERT, D.V.M. - THANNHAUSER, J. - MOL, J.Q. - ROOIJAKKERS, M.J.P. - VOS, J.L. - VAN RUMUND, A. - VART, P. - HASSING, R.J. - CORNEL, J.H. - DE JAGER, C.P.C. - VAN DEN HEUVEL, M.M. - VAN DER HOEVEN, H.G. - VERBON, A. - PINTO, Y.M. - VAN ROYEN, N. - VAN KIMMENADE, R.R.J. - DE LEEUW, P.W. - VAN AGTMAEL, M.A. - BRESSER, P. - VAN GILST, W.H. - VONK-NOORDERGRAAF, A. - TIJSSEN, J.G.P. Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease. In AMERICAN HEART JOURNAL. ISSN 0002-8703, AUG 2020, vol. 226, p. 60-68. KOW, C.S. - THIRUCHELVAM, K. - HASAN, S.S. Pharmacotherapeutic considerations for the management of cardiovascular diseases among hospitalized COVID-19 patients. In EXPERT REVIEW OF CARDIOVASCULAR THERAPY. ISSN 1477-9072, AUG 2 2020, vol. 18, no. 8, p. 475-485. MO, J. - LIU, J. - WU, S. - LÜ, A. - XIAO, L. - CHEN, D. - ZHOU, Y. - LIANG, L. - LIU, X. - ZHAO, J. Predictive role of clinical features in patients with Coronavirus disease 2019 for severe disease. In Journal of Central South University (Medical Sciences). ISSN 16727347, 2020-05-01, 45, 5, pp. 536-541. ALIAGA, A.A. - GARCÍA, R.de la Noval - VELIZ, D.H. Angiotensin ii convertering enzyme and the use of renine angiotensin aldosterone system inhibitors. Could it be a beneficial practice in covid-19 patients? In Revista Cubana de Cardiologia y Cirugia Cardiovascular, 2020-01-01, 26, 4, pp. 1-3. LIU, J. - CHEN, G.Q. - WEI, L. - JIAO, F.Y. A review on the role of angiotensin-converting enzyme 2 in children with coronavirus disease 2019. In Chinese Journal of Contemporary Pediatrics. ISSN 10088830, 2020-12-15, 22, 12, pp. 1344-1348. REZAEI, M. - ZIAI, S.A. - FAKHRI, S. - POURIRAN, R. ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID-19. In Journal of Cellular Physiology. ISSN 00219541, 2021-04-01, 236, 4, pp. 2430-2442. DU, Y.B. - ZHOU, N. - ZHA, W.T. - LV, Y. Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis. In NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES. ISSN 0939-4753, MAR 10 2021, vol. 31, no. 3, p. 745-755. HSU, C.N. - TAIN, Y.L. Targeting the Renin-Angiotensin-Aldosterone System to Prevent Hypertension and Kidney Disease of Developmental Origins. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. MAR 2021, vol. 22, no. 5, art. no. 2298. HAMEID, R.A. - CORMET-BOYAKA, E. - KUEBLER, W.M. - UDDIN, M. - BERDIEV, B.K. SARS-CoV-2 may hijack GPCR signaling pathways to dysregulate lung ion and fluid transport. In AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY. ISSN 1040-0605, MAR 2021, vol. 320, no. 3, p. L430-L435. GUNEY, C. - AKAR, F. Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes. In JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES. ISSN 1482-1826, FEB 23 2021, vol. 24, p. 84-93. BENGTSON, C.D. - MONTGOMERY, R.N. - NAZIR, U. - SATTERWHITE, L. - KIM, M.D. - BAHR, N.C. - CASTRO, M. - BAUMLIN, N. - SALATHE, M. An Open Label Trial to Assess Safety of Losartan for Treating Worsening Respiratory Illness in COVID-19. In FRONTIERS IN MEDICINE. FEB 17 2021, vol. 8, art. no. 630209. SAMANCI, C. - SAYLAN, B. - GULSEN, G. - AKKAYA, Y. - YESILDAL, M. - ISIK, S.A. - USTABASIOGLU, F.E. CT visual quantitative evaluation of hypertensive patients with coronavirus disease (COVID-19): Potential influence of angiotensin converting enzyme inhibitors / angiotensin receptor blockers on severity of lung involvement. In CLINICAL AND EXPERIMENTAL HYPERTENSION. ISSN 1064-1963, MAY 19 2021, vol. 43, no. 4, p. 341-348. ZIAI, S.A. - REZAEI, M. - FAKHRI, S. - POURIRAN, R. ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID-19. In JOURNAL OF CELLULAR PHYSIOLOGY. ISSN 0021-9541, APR 2021, vol. 236, no. 4, p. 2430-2442. MOMTAZI-BOROJENI, A.A. - BANACH, M. - REINER, E. - PIRRO, M. - BIANCONI, V. - AL-RASADI, K. - SAHEBKAR, A. Interaction Between Coronavirus S-Protein and Human ACE2: Hints for Exploring Efficient Therapeutic Targets to Treat COVID-19. In ANGIOLOGY. ISSN 0003-3197, FEB 2021, vol. 72, no. 2, p. 122-130. FEDELE, D. - DE FRANCESCO, A. - RISO, S. - COLLO, A. Obesity, malnutrition, and trace element de fi ciency in the coronavirus disease (COVID-19) pandemic: An overview. In NUTRITION. ISSN 0899-9007, JAN 2021, vol. 81, art. no. 111016. AMIRFAKHRYAN, H. - SAFARI, F. Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement. In HELLENIC JOURNAL OF CARDIOLOGY. ISSN 1109-9666, JAN-FEB 2021, vol. 62, no. 1, p. 13-23. CISMARU, A.C. - CISMARU, L.G. - NABAVI, S.F. - BERINDAN-NEAGOE, I. - CLEMENTI, E. - BANACH, M. - NABAVI, S.M. Game of "crowning" season 8: RAS and reproductive hormones in COVID-19-can we end this viral series?. In ARCHIVES OF MEDICAL SCIENCE. ISSN 1734-1922, FEB 2021, vol. 17, no. 2, p. 275-284. HAN, G.C. - SINJAB, A. - HARA, K. - TREEKITKARNMONGKOL, W. - BRENNAN, P. - CHANG, K. - BOGATENKOVA, E. - SANCHEZ-ESPIRIDION, B. - BEHRENS, C. - SOLIS, L.M. - GAO, B.I. - GIRARD, L. - ZHANG, J.N. - SEPESI, B. - CASCONE, T. - BYERS, L.A. - GIBBONS, D.L. - CHEN, J.C. - MOGHADDAM, S.J. - OSTRIN, E.J. - SCHEET, P. - FUJIMOTO, J. - SHAY, J. - HEYMACH, J.V. - MINNA, J.D. - DUBINETT, S. - WISTUBA, I.I. - STEVENSON, C.S. - SPIRA, A.E. - WANG, L.H. - KADARA, H. Single-Cell Expression Landscape of SARS-CoV-2 Receptor ACE2 and Host Proteases in Normal and Malignant Lung Tissues from Pulmonary Adenocarcinoma Patients. In CANCERS. MAR 2021, vol. 13, no. 6, art. no. 1250. WANG, S. - ZHANG, Q. - WANG, P. - YE, H.H. - JING, X.Q. - ZHANG, Z.D. - ZHU, S.S. - LUO, T.T. - ZHENG, Z.B. Clinical features of hypertensive patients with COVID-19 compared with a normotensive group: Single-center experience in China. In OPEN MEDICINE. ISSN 2391-5463, MAR 3 2021, vol. 16, no. 1, p. 367-374. AJMERA, V. - THOMPSON, W.K. - SMITH, D.M. - MALHOTRA, A. - MEHTA, R.L. - TOLIA, V. - YIN, J. - SRIRAM, K. - INSEL, P.A. - COLLIER, S. - RICHARDS, L. - LOOMBA, R. RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19. In CONTEMPORARY CLINICAL TRIALS. ISSN 1551-7144, APR 2021, vol. 103, art. no. 106330. OZ, M. - LORKE, D.E. - KABBANI, N. A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor. In PHARMACOLOGY & THERAPEUTICS. ISSN 0163-7258, MAY 2021, vol. 221, art. no. 107750. LEE, H.W. - YOON, C.H. - JANG, E.J. - LEE, C.H. Renin-angiotensin system blocker and outcomes of COVID-19: a systematic review and meta-analysis. In THORAX. ISSN 0040-6376, MAY 2021, vol. 76, no. 5, p. 479-486. SAAD, M.A.E. - FAHMY, M.I.M. - SAYED, R.H. - EL-YAMANY, M.F. - EL-NAGGAR, R. - HEGAZY, A.A.E. - AL-SHORBAGY, M. Eprosartan: A closer insight into its neuroprotective activity in rats with focal cerebral ischemia-reperfusion injury. In JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY. ISSN 1095-6670, JUL 2021, vol. 35, no. 7, art. no. e22796. LI, X.Y. - ZHONG, X.R. - WANG, Y.B. - ZENG, X.T. - LUO, T. - LIU, Q. Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis. In PLOS ONE. ISSN 1932-6203, MAY 3 2021, vol. 16, no. 5, art. no. e0250602. RAGHAVAN, S. - GAYATHRI, R. - KANCHARLA, S. - KOLLI, P. - RANJITHA, J. - SHANKAR, V. Cardiovascular Impacts on COVID-19 Infected Patients. In FRONTIERS IN CARDIOVASCULAR MEDICINE. ISSN 2297-055X, MAY 13 2021, vol. 8, art. no. 670659. SAJDEL-SULKOWSKA, E.M. A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency. In FRONTIERS IN PHARMACOLOGY. JUN 11 2021, vol. 12, art. no. 684610. JOGALEKAR, M.P. - VEERABATHINI, A. - PATEL, A.B. COVID-19: Antiviral agents and enzyme inhibitors/receptor blockers in development. In EXPERIMENTAL BIOLOGY AND MEDICINE. ISSN 1535-3702, JUL 2021, vol. 246, no. 13, p. 1533-1540. BAVISHI, C. - WHELTON, P.K. - MANCIA, G. - CORRAO, G. - MESSERLI, F.H. Impact of renin-angiotensin-aldosterone system inhibitor continuation on outcomes for patients with severe coronavirus disease 2019 manifestations Reply. In JOURNAL OF HYPERTENSION. ISSN 0263-6352, AUG 2021, vol. 39, no. 8, p. 1726-1727. BASLILAR, S. - SAYLAN, B. Patients with hypertension hospitalized with COVID-19 pneumonia using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers or other antihypertensives: retrospective analysis of 435 patients. In ANNALS OF SAUDI MEDICINE. ISSN 0256-4947, SEP-OCT 2021, vol. 41, no. 5, p. 268-273. HU, Y. - LIU, L.H. - LU, X.F. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?. In FRONTIERS IN ENDOCRINOLOGY. ISSN 1664-2392, OCT 22 2021, vol. 12, art. no. 725967. BADI, R. Acylated Ghrelin Attenuates L-Thyroxin-induced Cardiac Damage in Rats by Antioxidant and Anti-inflammatory Effects and Downregulating Components of the Cardiac Renin-angiotensin System. In JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. ISSN 0160-2446, SEP 2021, vol. 78, no. 3, p. 422-436. RAHMANI, W. - CHUNG, H. - SINHA, S. - BUI-MARINOS, M.P. - ARORA, R. - JAFFER, A. - CORCORAN, J.A. - BIERNASKIE, J. - CHUN, J. Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids. In ISCIENCE. FEB 18 2022, vol. 25, no. 2. EL-ARIF, G. - KHAZAAL, S. - FARHAT, A. - HARB, J. - ANNWEILER, C. - WU, Y.L. - CAO, Z.J. - KOVACIC, H. - KHATTAR, Z.A. - FAJLOUN, Z. - SABATIER, J.M. Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases. In MOLECULES. APR 2022, vol. 27, no. 7. YIN, Juntao - WANG, Chaoyang - SONG, Xiaoyong - LI, Xiumin - MIAO, Mingsan. Effects of Renin-Angiotensin System Inhibitors on Mortality and Disease Severity of COVID-19 Patients: A Meta-analysis of Randomized Controlled Trials. In AMERICAN JOURNAL OF HYPERTENSION, 2022, vol. 35, no. 5, pp. 462-469. ISSN 0895-7061. Dostupné na: https://doi.org/10.1093/ajh/hpac001. CHOOPANI, Samira - NEMATBAKHSH, Mehdi. Estradiol Supplement or Induced Hypertension May Attenuate the Angiotensin II Type 1 Receptor Antagonist-Promoted Renal Blood Flow Response to Graded Angiotensin II Administration in Ovariectomized Rats. In JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2022, vol. 2022, art. no. 3223008. ISSN 1470-3203. Dostupné na: https://doi.org/10.1155/2022/3223008. YANG, Jinqiang - LI, Ming - ZHANG, Renmin. Network meta-analysis of deaths from various underlying diseases after COVID-19 infection. In FRONTIERS IN PUBLIC HEALTH, 2022, vol. 10, art. no. 959073. Dostupné na: https://doi.org/10.3389/fpubh.2022.959073. ALI, S. - KHAN, O.S. - KHALIL, A.M. - ODEH, A.K. Admission Hyperglycemia as a Predictor of COVID-19 Pneumonia, Cytokine Release Syndrome Progression, and Clinical Outcomes in a Tertiary Care Hospital. In CUREUS JOURNAL OF MEDICAL SCIENCE. JUL 19 2022, vol. 14, no. 7. KHAJA, A.S.S. - ZAFAR, M. - ALMANSOUR, M. - ALSOHAIL, H. - ALMANSOUR, I. - SALEEM, M. Assessment of the severity of COVID-19 symptoms after vaccination among the Saudi population suffering from chronic conditions. In MEDICAL SCIENCE. ISSN 2321-7359, SEP 2022, vol. 26, no. 127. YOSHIHARA, F. - OHTSU, H. - NAKAI, M. - TSUZUKI, S. - HAYAKAWA, K. - TERADA, M. - MATSUNAGA, N. - YASUDA, S. - OGAWA, H. - OHMAGARI, N. Renin-angiotensin system blocker and the COVID-19 aggravation in patients with hypertension, diabetes, renal failure, Cerebro-cardiovascular disease, or pulmonary disease: Report by the COVID-19 Registry Japan. In JOURNAL OF CARDIOLOGY. ISSN 0914-5087, OCT 2022, vol. 80, no. 4, p. 292-297. FITERO, A. - BUNGAU, S.G. - TIT, D.M. - ENDRES, L. - KHAN, S.A. - BUNGAU, A.F. - ROMANUL, I. - VESA, C.M. - RADU, A.F. - TARCE, A.G. - BOGDAN, M.A. - NECHIFOR, A.C. - NEGRUT, N. Comorbidities, Associated Diseases, and Risk Assessment in COVID-19-A Systematic Review. In INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. ISSN 1368-5031, OCT 31 2022, vol. 2022. RANJBAR, T. - OZA, P.P. - KASHFI, K. The Renin-Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. NOV 2022, vol. 23, no. 22. HUANG, N.X. - YUAN, Q. - FANG, F. - YAN, B.P. - SANDERSON, J.E. Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in East-Asian patients with COVID-19. In PLOS ONE. ISSN 1932-6203, JAN 12 2023, vol. 18, no. 1. ZHOU, M.Z. - SONG, T.Y. - LI, W. - HUANG, M.T. - ZHENG, L. - ZHAO, M.M. Identification and Screening of Potential ACE2 Activating Peptides from Soybean Protein Isolate Hydrolysate against Ang II-Induced Endothelial Dysfunction. In JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY. ISSN 0021-8561, JUL 28 2023, vol. 71, no. 31, p. 11957-11969. KHEDERLOU, Hamid - HOSSEINI, Kaveh - RASOULI, Ahmadreza - SHARIF, Nafiseh - KAZEMI, Morteza - MEHRPOOYA, Maryam. Evaluation of Relationship Between Risk Factors of Cardiovascular Disease and Morbidity and Mortality of COVID-19 Patients. In Journal of Iranian Medical Council, 2023-03-01, 6, 1, pp. 72-81. ISSN 2645338X. Dostupné na: https://doi.org/10.18502/JIMC.V6I1.11845. YOSHIHARA, F. Association between blood pressure and COVID-19 severity. In HYPERTENSION RESEARCH. ISSN 0916-9636, MAR 2024, vol. 47, no. 3, p. 683-684. TURNIAK-KUSY, M. - STUDZIAN, M. - SZPAKOWSKI, P. - KUCHTA, P. - SMIETANKA, K. - MATTERN, C. - PULASKI, L. - BIELECKI, B. Testosterone Inhibits Secretion of the Pro-Inflammatory Chemokine CXCL1 from Astrocytes. In CURRENT ISSUES IN MOLECULAR BIOLOGY. ISSN 1467-3037, MAR 2024, vol. 46, no. 3, p. 2105-2118. TAIN, Y.L. - HSU, C.N. The Renin-Angiotensin System and Cardiovascular-Kidney-Metabolic Syndrome: Focus on Early-Life Programming. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. ISSN 1661-6596, MAR 2024, vol. 25, no. 6, art. no. 3298. ABUIESSA, Salwa A. - HELMY, Mai M. - EL-GOWELLI, Hanan M. - EL-GOWILLY, Sahar M. - EL-MAS, Mahmoud M. Gestationally administered RAS modulators reprogram endotoxic cardiovascular and inflammatory profiles in adult male offspring of preeclamptic rats. In Naunyn-Schmiedeberg's Archives of Pharmacology, 2024-01-01, pp. ISSN 00281298. Dostupné na: https://doi.org/10.1007/s00210-024-03305-2. Kategória ADCA - Vedecké práce v zahraničných karentovaných časopisoch impaktovaných Kategória (od 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Typ výstupu článok Rok vykazovania 2015 Registrované v WOS Registrované v SCOPUS Registrované v CCC 
článok
rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2015 2014 4.014 Q1 1.938 Q1
Počet záznamov: 1